According to the TIDE database, EZH2 expression showed a significant positive correlation with dysfunctional T-cell phenotypes of KIRC, LUAD, BRCA, HNSC, myeloma, and colorectal cancer. This evidence concerns the gene EZH2 and colorectal cancer.